Several compounds, including ellagic acid, quercetin, curcumin, kaempferol, and hesperetin, display relatively high binding affinities for both AChE and Amyloid-β, suggesting their potential as dual-targeting agents for the treatment of neurodegenerative diseases like Alzheimer’s. This evidence concerns the gene ACHE and neurodegenerative disease.